Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement

被引:2
|
作者
Yera, Hassan O. [1 ]
Khan, Ahsan [2 ]
Akinlade, Olawale M. [3 ]
Champsi, Asgher [2 ]
Glouzon, Van Nam J. [4 ]
Spencer, Charles [2 ]
机构
[1] Shrewsbury & Telford Hosp NHS Trust, Internal Med, Telford, England
[2] New Cross Hosp, Cardiol Heart & Lung Ctr, Wolverhampton, England
[3] Dumfries & Galloway Royal Infirm, Cardiol, Dumfries, Scotland
[4] New Cross Hosp, Internal Med Heart & Lung Ctr, Wolverhampton, England
关键词
morbidity and mortality; heart failure with reduced ejection fraction; quality improvement; ferric carboxymaltose; iron deficiency anaemia; REDUCED EJECTION FRACTION; FERRIC CARBOXYMALTOSE; EXERCISE CAPACITY; ANEMIA; SUBANALYSIS; PREVALENCE; THERAPY;
D O I
10.7759/cureus.47027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Iron deficiency (ID) has been shown to be a significant co-morbidity in patients with heart failure (HF), independent of their anaemia status. Correction of ID has been shown to improve quality of life, recurrent heart failure hospitalizations and morbidity. A quality improvement project was designed to improve the assessment and treatment of iron deficiency in HF patients in our tertiary care centre.Methods and results An initial baseline dataset was collected, followed by two cycles of interventions to help improve the care of HF patients admitted to our hospital over a two-month period. The Plan-Do-Study-Act (PDSA) cycle approach was applied, with the first intervention involving raising awareness of the importance and need to assess the iron status of HF patients through education provided to doctors, nurses and patients. Furthermore, information leaflets were produced and disseminated across the medical wards and through social media forums. The post-intervention datasets were collected and compared to the baseline outcomes. Baseline data showed that only four (20%) of heart failure patients had their iron status checked. Following the interventions, screening for ID increased to 80% (16), of which 85% (11) of those who identified as iron deficient received intravenous iron replacement.Conclusion The project was successful in improving the practice of screening for iron deficiency and intravenous replacement of iron in patients with HF.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency
    Cheema, Baljash
    Chokshi, Anuj
    Orimoloye, Olusola
    Ardehali, Hossein
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (25) : 2674 - 2689
  • [2] IMPROVING THE ASSESSMENT OF IRON STATUS AND REPLACEMENT AMONG HEART FAILURE PATIENTS
    Yera, Hassan
    Khan, Ahsan
    Akinlade, Olawale
    Champsi, Asgher
    Glouzon, Van Nam
    Spencer, Charles
    [J]. HEART, 2022, 108 : A97 - A97
  • [3] Extending the Evidence for Intravenous Iron in Patients With Heart Failure and Iron Deficiency
    Gale, Stormi E.
    [J]. JACC-HEART FAILURE, 2024, 12 (03) : 537 - 538
  • [4] Ironing Out the Details: Increasing the Screening of Iron Deficiency in Heart Failure Patients and the Promotion of Intravenous Iron Replacement
    Ruiz, Gabriel
    Wilson, Zachary
    Abdelhabib, Mohamed
    Vukomanovic, Damir
    Patel, Vikeen J.
    Tandon, Varun
    Pandya, Shaunak
    Anderson, Dustin
    Crawford, Julie
    Mehr, Ali
    [J]. CIRCULATION, 2021, 144
  • [5] Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence
    Gale, Stormi E.
    Willeford, Andrew
    Sandquist, Katherine
    Watson, Kristin
    [J]. CURRENT OPINION IN CARDIOLOGY, 2024, 39 (03) : 178 - 187
  • [6] Iron deficiency screening and intravenous iron in patients followed by a heart failure clinic and hospitalised for acute heart failure
    Boisvert, J.
    Morin, R.
    Leclerc, V.
    Methot, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 423 - 423
  • [7] Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: a Bayesian meta-analysis
    Anker, Stefan D.
    Khan, Muhammad Shahzeb
    Butler, Javed
    von Haehling, Stephan
    Jankowska, Ewa A.
    Ponikowski, Piotr
    Friede, Tim
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 1080 - 1090
  • [8] Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis
    Graham, Fraser J.
    Pellicori, Pierpaolo
    Kalra, Paul R.
    Ford, Ian
    Bruzzese, Dario
    Cleland, John G. F.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (04) : 528 - 537
  • [9] MANAGING IRON DEFICIENCY ANEMIA IN PATIENTS WITH HEART FAILURE: IMPACT OF INTRAVENOUS IRON SELECTION
    Fudim, Marat
    Burkle, Jaime
    Polson, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 385 - 385
  • [10] Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency
    Doehner, Wolfram
    von Haehling, Stephan
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (09) : 1165 - 1165